4//SEC Filing
KIM AUSTIN D. 4
Accession 0001209191-23-052390
CIK 0001070494other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 10:00 PM ET
Size
9.3 KB
Accession
0001209191-23-052390
Insider Transaction Report
Form 4
KIM AUSTIN D.
EVP AND GENERAL COUNSEL
Transactions
- Exercise/Conversion
Common Stock
2023-10-05+36,174→ 62,226 total - Exercise/Conversion
Restricted Stock Units
2023-10-05−36,174→ 60,289 total→ Common Stock (36,174 underlying) - Sale
Common Stock
2023-10-06$21.96/sh−16,369$359,463→ 45,857 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F2]Includes 539 shares acquired by the Reporting Person under the Issuer's 2004 Employee Stock Purchase Plan on May 15, 2023.
- [F3]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F4]Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001746240
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 10:00 PM ET
- Size
- 9.3 KB